CytomX Therapeutics (CTMX) Net Income (2014 - 2026)
CytomX Therapeutics (CTMX) posted Net Income of -$18.2 million for Q1 2026, up 19.52% on a QoQ basis from -$22.7 million in Q4 2025, and down 177.57% year-over-year from $23.5 million in Q1 2025.
CytomX Therapeutics (CTMX) Net Income (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Net Income history runs 13 years deep, the most recent figure standing at -$18.2 million for Q1 2026.
- Quarterly Net Income fell 177.57% year-over-year to -$18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.3 million (down 232.94% YoY) and the FY2025 annual result came in at -$13.5 million, down 142.46% from the prior year.
- Net Income was -$18.2 million for Q1 2026 at CytomX Therapeutics, up from -$22.7 million in the prior quarter.
- Across five years, Net Income topped out at $23.5 million in Q1 2025 and bottomed at -$32.0 million in Q1 2022.
- A 5-year average of -$5.9 million and a median of -$3.3 million in 2023 frame the typical range for Net Income.
- Peak annual rise in Net Income reached 2155.2% in 2024, while the deepest fall reached 501.1% in 2024.
- CytomX Therapeutics' Net Income stood at -$8.8 million in 2022, then surged by 109.54% to $837000.0 in 2023, then soared by 2155.2% to $18.9 million in 2024, then sank by 220.12% to -$22.7 million in 2025, then gained by 19.52% to -$18.2 million in 2026.
- Business Quant data shows CTMX's Net Income at -$18.2 million in Q1 2026, -$22.7 million in Q4 2025, and -$14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | -18.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.25 Mn |
| Dec 31, 2025 | -22.67 Mn |
| Sep 30, 2025 | -14.23 Mn |
| Jun 30, 2025 | -154,000.00 |
| Mar 31, 2025 | 23.53 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | -6.53 Mn |
| Mar 31, 2024 | 13.79 Mn |
| Dec 31, 2023 | 837,000.00 |
| Sep 30, 2023 | 2.99 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -8.78 Mn |
| Sep 30, 2022 | -29.06 Mn |
| Jun 30, 2022 | -29.50 Mn |
| Mar 31, 2022 | -31.98 Mn |
| Dec 31, 2021 | -34.82 Mn |
| Sep 30, 2021 | -30.98 Mn |
| Jun 30, 2021 | -26.74 Mn |